Author:
Greifenkamp Jonathan D.,DiPette Donald J.
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Kangawa K, Kitamura K, Minamino N, et al.: Adrenomedullin: a new hypotensive peptide. J Hypertens Suppl 1996, 14:S105-S110.
2. Kapas S, Martinez A, Cuttitta F, Hinson JP: Local production and action of adrenomedullin in the rat adrenal zona glomerulosa. J Endocrinol 1998, 156:477–484. This excellent study suggests that ADM is synthesized in both the adrenal medullary and cortical cells. It also indicates that ADM receptors are present throughout the adrenal cortex, and hypothesizes that ADM may have an autocrine-paracrine role in the regulation of the rat adrenal gland.
3. Di Pette DJ, Supowit SC: Calcitonin gene-related peptide and hypertension. In Hypertension. Edited by Oparil S. Philadelphia: WB Saunders; in press.
4. HinsonJP, Kapas S: The role of endothelial cell products in the regulation of adrenocortical function: actions of endothelin, nitric oxide, adrenomedullin and PAMP. Horm Metab Res 1998, 30:334–340. This excellent review discusses the controversies surrounding the issues of autocrine-paracrine regulation of adrenal function by endothelin, nitric oxide, ADM, and PAMP.
5. Lainchbury JG, Cooper G, Coy DH, et al.: Adrenomedullin: a hypotensive hormone in man. Clin Sci 1997, 92:467–472. This paper, which was the first full report of a study on the biological effects of ADM in humans, reported that ADM was capable of reducing arterial blood pressure in low picomolar concentrations in a healthy man.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献